Smoking Cessation Aids in Japan
1. EXECUTIVE SUMMARY
2. OPERATING ENVIRONMENT
2.1 OTC Registration and Classification
2.2 Vitamins & Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homeopathy
2.9 Generics
2.10 Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 1999-2004
2.11 Life Expectancy
Table 2 Life Expectancy at Birth 1999-2004
3. OTC HEALTHCARE SALES
3.1 Market Performance
Table 3 Sales of OTC Healthcare by Sector: Value 1999-2004
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 1999-2004
3.2 Switches
Summary 1 OTC Healthcare Switches 2003-2004
3.3 Key Trends and Developments
3.4 Competitive Environment
Table 5 OTC Healthcare Company Shares 2001-2004
Table 6 OTC Healthcare Brand Shares 2001-2004
3.5 Leading Company Profiles: Amway Japan Ltd
Summary 2 Amway Japan Ltd Operational Indicators 2004
Table 7 Amway Japan Ltd Shares of OTC Healthcare by Subsector 2001-2004
3.6 Leading Company Profiles: Eisai Co Ltd
Summary 3 Eisai Co Ltd Operational Indicators 2004
Table 8 Eisai Co Ltd Shares of OTC Healthcare by Subsector 2001-2004
3.7 Leading Company Profiles: Hisamitsu Pharmaceutical Co Inc
Summary 4 Hisamitsu Pharmaceutical Co Inc Operational Indicators 2004
Table 9 Hisamitsu Pharmaceutical Co Inc Shares of OTC Healthcare by Subsector 2001-2004
3.8 Leading Company Profiles: Lion Corp
Summary 5 Lion Corp Operational Indicators 2004
Table 10 Lion Corp Shares of OTC Healthcare by Subsector 2001-2004
3.9 Leading Company Profiles: Meiji Seika Kaisha Co Ltd
Summary 6 Meiji Seika Kaisha Co Ltd Operational Indicators 2004
Table 11 Meiji Seika Kaisha Co Ltd Shares of OTC Healthcare by Subsector 2001-2004
3.10 Leading Company Profiles: Otsuka Pharmaceutical Co Ltd
Summary 7 Otsuka Pharmaceutical Co Ltd Operational Indicators 2004
Table 12 Otsuka Pharmaceutical Co Ltd Shares of OTC Healthcare by Subsector 2001-2004
3.11 Leading Company Profiles: Rohto Pharmaceutical Co Ltd
Summary 8 Rohto Pharmaceutical Co Ltd Operational Indicators 2004
Table 13 Rohto Pharmaceutical Co Ltd Shares of OTC Healthcare by Subsector 2001-2004
3.12 Leading Company Profiles: Sankyo Co Ltd
Summary 9 Sankyo Co Ltd Operational Indicators 2004
Table 14 Sankyo Co Ltd Shares of OTC Healthcare by Subsector 2001-2004
3.13 Leading Company Profiles: Sato Pharmaceutical Co Ltd
Table 15 Sato Pharmaceutical Co Ltd Shares of OTC Healthcare by Subsector 2001-2004
3.14 Leading Company Profiles: SSP Co Ltd
Summary 10 SSP Co Ltd Operational Indicators 2004
Table 16 SSP Co Ltd Shares of OTC Healthcare by Subsector 2001-2004
3.15 Leading Company Profiles: Takeda Pharmaceutical Co Ltd
Summary 11 Takeda Pharmaceutical Co Ltd Operational Indicators 2004
Table 17 Takeda Pharmaceutical Co Ltd Shares of OTC Healthcare by Subsector 2001-2004
3.16 Retail Distribution
Table 18 Sales of OTC Healthcare by Distribution Format: % Analysis 1999/2004
Table 19 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2004
3.17 Retailer Activity and Private Label Trends
Table 20 Penetration of Private Label by Sector 2001-2004
3.18 Forecast Market Performance
Table 21 Forecast Sales of OTC Healthcare by Sector: Value 2004-2009
Table 22 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2004-2009
4. SMOKING CESSATION AIDS SALES
4.1 Number of Smokers
Table 23 Number of Smokers by Gender 1999-2004
4.2 Sector Performance
Table 24 Sales of Smoking Cessation Aids by Subsector: Value 1999-2004
Table 25 Sales of Smoking Cessation Aids by Subsector: % Value Growth 1999-2004
Table 26 Smoking Cessation Aids Company Shares 2001-2004
Table 27 Smoking Cessation Aids Brand Shares 2001-2004
Table 28 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2004-2009
Table 29 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2004-2009
4.3 New Product Developments
Summary 12 Smoking Cessation Aids: New Product Launches 2003-2004
5. OTHER OTC
6. DEFINITIONS
